These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 18494062)
1. Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients. Wang YC; Yu ZH; Liu C; Xu LZ; Yu W; Lu J; Zhu RM; Li GL; Xia XY; Wei XW; Ji HZ; Lu H; Gao Y; Gao WM; Chen LB World J Gastroenterol; 2008 May; 14(19):3074-80. PubMed ID: 18494062 [TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681 [TBL] [Abstract][Full Text] [Related]
3. Aberrant CpG island hypermethylation of RASSF1A in gastric cardia adenocarcinoma. Guo W; Dong Z; Chen Z; Yang Z; Wen D; Kuang G; Guo Y; Shan B Cancer Invest; 2009 May; 27(4):459-65. PubMed ID: 19160099 [TBL] [Abstract][Full Text] [Related]
4. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients. Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472 [TBL] [Abstract][Full Text] [Related]
5. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730 [TBL] [Abstract][Full Text] [Related]
6. CpG island promoter hypermethylation of Ras association domain family 1A gene contributes to gastric carcinogenesis. Joo MK; Kim KH; Park JJ; Yoo HS; Choe J; Kim HJ; Lee BJ; Kim JS; Bak YT Mol Med Rep; 2015 Apr; 11(4):3039-46. PubMed ID: 25483734 [TBL] [Abstract][Full Text] [Related]
7. Aberrant hypermethylation of RASSF1A promoter in ovarian borderline tumors and carcinomas. Choi YL; Kang SY; Shin YK; Choi JS; Kim SH; Lee SJ; Bae DS; Ahn G Virchows Arch; 2006 Mar; 448(3):331-6. PubMed ID: 16315018 [TBL] [Abstract][Full Text] [Related]
8. Polymorphism of A133S and promoter hypermethylation in Ras association domain family 1A gene (RASSF1A) is associated with risk of esophageal and gastric cardia cancers in Chinese population from high incidence area in northern China. Zhou SL; Cui J; Fan ZM; Li XM; Li JL; Liu BC; Zhang DY; Liu HY; Zhao XK; Song X; Wang R; Yan ZC; Yi HX; Wang LD BMC Cancer; 2013 May; 13():259. PubMed ID: 23705663 [TBL] [Abstract][Full Text] [Related]
9. Analysis of the RUNX3 gene methylation in serum DNA from esophagus squamous cell carcinoma, gastric and colorectal adenocarcinoma patients. Zheng Y; Zhang Y; Huang X; Chen L Hepatogastroenterology; 2011; 58(112):2007-11. PubMed ID: 22234069 [TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation of RASSF1A, MGMT, and HIC-1 genes in benign and malignant colorectal tumors. Abouzeid HE; Kassem AM; Abdel Wahab AH; El-mezayen HA; Sharad H; Abdel Rahman S Tumour Biol; 2011 Oct; 32(5):845-52. PubMed ID: 21274674 [TBL] [Abstract][Full Text] [Related]
11. DNA methylation of the p14ARF, RASSF1A and APC1A genes as an independent prognostic factor in colorectal cancer patients. Nilsson TK; Löf-Öhlin ZM; Sun XF Int J Oncol; 2013 Jan; 42(1):127-33. PubMed ID: 23128528 [TBL] [Abstract][Full Text] [Related]
12. Promoter methylation and expression of TIMP3 gene in gastric cancer. Guan Z; Zhang J; Song S; Dai D Diagn Pathol; 2013 Jul; 8():110. PubMed ID: 23819566 [TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of RARβ2 correlates with high COX-2 expression and poor prognosis in patients with colorectal carcinoma. Miladi-Abdennadher I; Abdelmaksoud-Damak R; Ayadi L; Khabir A; Frikha F; Kallel L; Amouri A; Frikha M; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R Tumour Biol; 2010 Oct; 31(5):503-11. PubMed ID: 20571967 [TBL] [Abstract][Full Text] [Related]
15. Potential of RASSF1A promoter methylation as a biomarker for colorectal cancer: Meta-analysis and TCGA analysis. Hu F; Chen L; Bi MY; Zheng L; He JX; Huang YZ; Zhang Y; Zhang XL; Guo Q; Luo Y; Tang WR; Sheng MM Pathol Res Pract; 2020 Aug; 216(8):153009. PubMed ID: 32703486 [TBL] [Abstract][Full Text] [Related]
16. High frequency of promoter hypermethylation of RASSF1A in tumorous and non-tumourous tissue of breast cancer. Yeo W; Wong WL; Wong N; Law BK; Tse GM; Zhong S Pathology; 2005 Apr; 37(2):125-30. PubMed ID: 16028839 [TBL] [Abstract][Full Text] [Related]
18. [Analysis of RASSF1A promoter hypermethylation in serum DNA of non-small cell lung cancer]. Yu ZH; Wang YC; Chen LB; Song Y; Liu C; Xia XY; Lin Q; Ma CY Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):284-7. PubMed ID: 18788633 [TBL] [Abstract][Full Text] [Related]
19. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix. Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945 [TBL] [Abstract][Full Text] [Related]
20. Association of diminished expression of RASSF1A with promoter methylation in primary gastric cancer from patients of central China. Ye M; Xia B; Guo Q; Zhou F; Zhang X BMC Cancer; 2007 Jul; 7():120. PubMed ID: 17608924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]